Financials
Financial year 2025
QUIDDITAS from Liège, company number BE0794472362, closed financial year 2025 with a result of € 127,985 after tax. For that financial year QUIDDITAS recorded a gross margin of € 175,986 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € -26,028 to € 127,985. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.
€ 1.1 million
▲ € 1 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 127,985
▲ still € 26,028 loss in 2024
Profit after tax over the fiscal year.
€ 749,235
▲ € 748,701 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 84,294.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 11,351
€ 11,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,903
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,198
▼ 91% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 40
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -9,392 | € -9,019 | € 175,986 | ▲ € 185,004 |
| Profit after taxes | € -17,663 | € -26,028 | € 127,985 | ▲ € 154,013 |
| Equity | € 58,487 | € 117,734 | € 1,145,848 | ▲ € 1 million |
| Total debts | € 110,126 | € 48,799 | € 39,329 | ▼ 19% |
| Cash | € 128 | € 535 | € 749,235 | ▲ € 748,701 |
| Retained profit | € -17,663 | € -43,691 | € 84,294 | ▲ € 127,985 |
| Balance sheet total | € 168,612 | € 166,532 | € 1,185,177 | ▲ € 1 million |
| Employees (FTE) | - | - | 1 |
Key figures of QUIDDITAS, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to QUIDDITAS?
What happened at QUIDDITAS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 127,985. Source: NBB ↗
- Aurore PRUNEVIEILLE became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 17,663 loss in 2023 to € 127,985 profit in 2025.
Paid € 172 in corporate taxes since 2023.
Best year ever: 2025, with € 127,985 profit.
On average € 176,000 of value added per employee in 2025.
A new publication or filing at QUIDDITAS? We notify you, reason included.
Follow QUIDDITASDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind QUIDDITAS are Aurore PRUNEVIEILLE and François Jean CHERBONNEAU. The shares are held by Françoise SHNEIKER, Emmanuel LEONARD, LUC PRUNEVIEILLE, B2G LIFE SCIENCES, Thomas MUFFAT-JEANDET and Victoire PRUNEVIEILLE. It owns 100% of Quidditas Therapeutics SAS itself.
Directors
According to the 2025 annual accounts
Aurore PRUNEVIEILLE
Director
Is a shareholder
since 2025
François Jean CHERBONNEAU
Administrateur Statutaire
Is a shareholder
Shareholders
Françoise SHNEIKER
Emmanuel LEONARD
LUC PRUNEVIEILLE
B2G LIFE SCIENCES
Thomas MUFFAT-JEANDET
Victoire PRUNEVIEILLE
IXLIFE
Alain BARONNIER
Laurent BRACCO
Aurore PRUNEVIEILLE · director
Thierry MARUCHEAU DE CHANAUD
Renaud Mascarin
Héloïse Mascarin
MIRABELLEBAM
EMPORIO SUN
Anna BONDARENKO
SYGA GROUP
THALEO EUROPE LTD
Marc BATROUNI
Mohamed Raed HERGLI
ETS PRUNEVIEILLE
François Jean CHERBONNEAU · director
Participations
Establishments
Establishment units
Physical locations of this company
Avenue Hippocrate 5
4000 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →XeroThera Europe
€ 196,870 gross margin · 2025
Sagitta Biotech
€ -138,661 gross margin · 2025
ARTIALIS
€ 320,267 gross margin · 2024
Temple OrthoBiologics
€ -225,322 gross margin · 2025
BRENUS PHARMA BELGIUM
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
LEVEL27-AS * Please direct all complaints to [email protected] *, BE
Domain
Domain
spronken.com
Registered
1999-03-31
Registrar
Combell NV
Expires
2026-03-31
Website info
Features
Security
Details
- Company number
- 0794.472.362
- VAT number
- BE 0794.472.362
- Registered office
- Avenue Hippocrate 5, 4000 Liège
- Names & denominations
- QUIDDITAS · QD
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 6 December 2022
- Peppol
- Active · Active since 13 Jun 2025
- Contact
- spronken.com
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied